Pediatric Ilioinguinal / Iliohyogogastric Nerve Block

Sponsor
Erzincan University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02990884
Collaborator
(none)
60
3
9

Study Details

Study Description

Brief Summary

Ilioinguinal / iliohyogogastric nerve blocks; It is frequently used for analgesia and anesthesia in inguinal region surgeons. However, 95% of these surgeons are under general anesthesia. aim of this study; Intra-operative anesthesia and analgesia effects of ilioinguinal / iliohyogogastric nerve block supported by ketamine sedation only.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Supportive Care
Official Title:
Influence of Ultrasonography Guided Ilioinguinal / Iliohipogastric Block in Intraoperative Anesthesia in Children - Randomized Controlled Study
Study Start Date :
Dec 1, 2016
Anticipated Primary Completion Date :
Jul 1, 2017
Anticipated Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: block and ketamine

Ilioinguinal / iliohypogastric block after ketamine atropine induction and continued with ketamine only in anesthesia

Drug: ketamine

Active Comparator: ketamine atropine; laryngeal mask

After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane MAC and oxygen / air mixture and applied Ilioinguinal / iliohypogastric block.

Drug: ketamine

Active Comparator: control group

After ketamine atropine induction, a laryngeal mask was inserted and anesthesia administration was continued with 2 sevoflurane MAC and oxygen / air mixture and Non-block, postoperative analgesia with paracetamol IV

Drug: ketamine

Outcome Measures

Primary Outcome Measures

  1. the amount of anesthetic drug which was used [nine month]

Secondary Outcome Measures

  1. Postoperative visual analogue scale [nine month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 6 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA I-II

  • To undergo elective lower abdominal surgery

  • between 2-6 years old

Exclusion Criteria:
  • Patients with psychiatric disease

  • Patients whose weight is more than 40 kg

  • Patients with cardiac-pulmonary-neurological disease

  • Patients with bleeding disorder

  • Patients with infection or scar on the injection area

  • Patients with known allergies to local anesthetics

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Erzincan University

Investigators

  • Principal Investigator: ilke kupeli, Erzincan University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
ILKE KUPELI, assist. prof., Erzincan University
ClinicalTrials.gov Identifier:
NCT02990884
Other Study ID Numbers:
  • ERZINCAN UNIVERSITY 6
First Posted:
Dec 13, 2016
Last Update Posted:
Dec 13, 2016
Last Verified:
Dec 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by ILKE KUPELI, assist. prof., Erzincan University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 13, 2016